Findings in this study show that the difference between T1D patients and their age-matched controls in terms of serum TGF- β concentration is mostly related to the disease status because patients and controls have been matched for notable criteria such as age.
Notable exclusion criteria include: age>65 years, poor quality mRNA, and significant structural brain pathology on post-mortem examination.
Notable exclusion criteria included history of cardiovascular disease, uncontrolled hypertension, eGFR of less than 55 mL/min/1.73 m (or <60 mL/min/1.73 m based on study center metformin labeling), or serum creatinine greater than 124 μmol/L for men and greater than 115 μmol/L for women.
Notable study exclusion criteria included: Bipolar Disorder (BP-I/II or NOS), a history of psychosis, current (<6 months) drug/alcohol abuse or dependence, history of seizures or known increased seizure risk, and any unstable medical condition.
Nominations are accepted if they fill the criterion of notable achievement, and only two have been rejected.
However, it is notable that this eligibility criterion resulted in the exclusion of only six individuals screened.
Notable proposals of such criteria were stated in terms of sparse coding in [6], already discussed in [3], and more recently in [7], or in terms of Bayesian learning [8].
Nevertheless, they identified relatively few genes that met their criteria of notable outliers in the proteome/transcriptome comparisons.
Pathway analysis, using genes selected on the basis of relaxed criteria, revealed notable differences between these two traits.
It is notable that the Venice criteria include, under "replication C," also the possibility of "no association and failed replication," based on traditional nonsignificant results for the meta-analysis.
